| Literature DB >> 31949962 |
Abstract
A 56-year-old female with a history of chronic alcoholism until age 38 y with a relapse between ages 45 and 46 y developed seizures, psychosis, and hemianopia to the left at age 46 y. Imaging revealed a right parieto-occipital lesion with intralesional bleeding. Five months after the first lesion she developed a second left parieto-occipital lesion, resulting in cortical blindness. Extensive workup, including brain biopsy, was noninformative. Retrospectively, the occipital abnormalities were identified as stroke-like lesions (SLLs). Further manifestations of the mitochondrial disorder (MID) were tremor, cerebral atrophy, bilateral basal ganglia, calcification, glaucoma, hypoacusis, short stature, hyperostosis frontalis, hyperthyroidism, sick-sinus syndrome and AV-block-1, and myopathy. According to the Walker criteria, a possible MID was diagnosed. In conclusion, adult-onset MID may be missed for years, SLLs may be easily misinterpreted entailing brain biopsy, and psychosis may contribute to a reduced impact for proper workup of a MID.Entities:
Year: 2019 PMID: 31949962 PMCID: PMC6948273 DOI: 10.1155/2019/9312451
Source DB: PubMed Journal: Case Rep Neurol Med ISSN: 2090-6676
Disease trajectory of the presented patient.
| Onset, age | Manifestation | Therapy |
|---|---|---|
| 16 y | Collapse with TBI (petrous bone fracture) | Conservative |
| 23 y | Right bimalleolar fracture | Np |
| Until 38 y | Chronic alcoholism | Withdrawal |
| 39 y | Icterus, hepatopathy | None |
| 43 y | Small breasts | Breast silicon implants |
| 45–46 y | Relapse of alcoholism | Successful withdrawal |
| 46 y | Epilepsy with focal and generalized seizures | Levetiracetam |
| 46 y | 1 SLL with intralesional bleeding (right occipital) hemianopia and neglect to the left, psychosis | Neuroleptics |
| 46 y | Hepatopathy, steatosis hepatis | None |
| Until age 46 y | Smoking | Withdrawal |
| 46 y | Acne rosacea | Topic ointments |
| 46 y | Arachnoidal cyst (left temporo-basal) | None |
| 46 y | Folic acid deficiency | Folic acid |
| 46 y | Hyperlipidemia | Diet |
| 46 y | 2 SLE (left occipital (epilepsy, psychosis, cortical blindness, and optic hallucinations)) | Brain biopsy via drill-hole quetiapin |
| 47 y | Arterial hypertension | Bisoprolol |
| 47 y | AV-block-1 | None |
| 47 y | Hyponatremia after adding OXC | OXC replaced with CBZ |
| Since age 47 y | Thrombocytopenia after adding CBZ | CBZ withdrawal |
| 47 y | Myoclonic seizure | Levetiracetam |
| 49 y | Glaucoma | Latanoprost |
| Until 49 y | Recurrent syncopes due to sinus arrests | Pacemaker |
| 49 y | Hyperthyroidism | None |
| 53 y | Capsular fibrosis | Replacement of breast implants |
| 53 y | Ischemic strokes (PCAS territory, PCAS stenosis) | Antithrombotics |
| 56 y | Barrett esophagus | Esomeprazole |
| 56 y | Hyperostosis frontalis | None |
| 56 y | Generalized brain atrophy | None |
| Since years | Carpopedal spasms | Magnesium |
| Since years | Hypoacusis | None |
PCAS: left posterior cerebral artery syndrome, PRES: posterior reversible encephalopathy syndrome, SLE: stroke-like episode, AEDs: antiepileptic drugs, SSS: sick-sinus syndrome, TBI: traumatic brain injury, CBZ: carbamazepine, and np: not provided.
Figure 1Cerebral MRI, 2 months after onset of psychosis, epilepsy, and visual impairment showing a slightly hyperintense right occipital lesion and a slightly hypointense similar lesion in the left occipital area, which were both hyperintense on ADC and hyperintense on T2-weighted images. Within the right occipital lesion, cortical and subcortical bleeding was identified. The occipital lesions were retrospectively interpreted as consecutive, subacute SLLs.
MIMODS score calculated as the sum of three items.
| (1) Number of affected organs (range: 0–14) |
| (muscle, CNS, endocrine organs, heart, intestines, nerves, ears, eyes, bone marrow, kidneys, skin, bones, lungs, and arteries) |
| (2) Number of manifestations per organ |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| (3) Frequency of citations in PubMed (>100 citations: 3 points, 50–100 citations: 2 points, <50 citations; 1 point); |
A score >11 suggests definite MID; the PubMed value is provided in parenthesis after each manifestation.